| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | Director | Common Stock | 66.8K | $1.4M | $21.00 | Jun 24, 2021 | Direct |
| Ultragenyx Pharmaceutical Inc. | Director | Common Stock | 10.5K | $220K | $21.00 | Jun 24, 2021 | By trust |
| X4 Pharmaceuticals, Inc | Director | Common Stock | 96.7K | $85.2K | $0.88 | Jun 10, 2024 | Direct |
| Ultragenyx Pharmaceutical Inc. | Director | Stock Option (Right to Buy) | 4.13K | Jun 24, 2021 | Direct | ||
| APPLIED GENETIC TECHNOLOGIES CORP | Director | Common Stock | 0 | $0.77 | Nov 30, 2022 | Direct | |
| APPLIED GENETIC TECHNOLOGIES CORP | Director | Stock Option (Right to Buy) | 0 | Nov 30, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| XFOR | X4 Pharmaceuticals, Inc | Jun 10, 2024 | 1 | $0 | 4 | Jun 11, 2024 | Director |
| XFOR | X4 Pharmaceuticals, Inc | Jun 13, 2023 | 1 | $0 | 4 | Jun 14, 2023 | Director |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Nov 30, 2022 | 6 | $0 | 4 | Dec 1, 2022 | Director |
| XFOR | X4 Pharmaceuticals, Inc | Jun 6, 2022 | 1 | $0 | 4 | Jun 27, 2022 | Director |
| AGTC | APPLIED GENETIC TECHNOLOGIES CORP | Nov 30, 2021 | 1 | $0 | 4 | Dec 2, 2021 | Director |
| RARE | Ultragenyx Pharmaceutical Inc. | Jun 24, 2021 | 2 | $0 | 4 | Jun 28, 2021 | Director |
| XFOR | X4 Pharmaceuticals, Inc | Jun 2, 2021 | 1 | $57K | 4 | Jun 2, 2021 | Director |